Skip to Content

MultiCorp International Inc MCIC Stock Quote

| Rating as of


Morningstar‘s Stock Analysis MCIC

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics MCIC

Company Profile MCIC

Business Description

MultiCorp International Inc engages in the medical business in the United States. The company is in the development stage of patented migraine medicine.

5308 Derry Avenue, Suite R
Agoura Hills, CA, 91301
T +1 818 255-2222
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022